default author photo

Marie Bernadi

Institut d'Administration des Entreprises d'Aix-en-Provence (IAE Aix)

SCHOLARLY PAPERS

2

DOWNLOADS

96

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Real-World Efficacy and Safety of Combination Nivolumab Plus Ipilimumab for Untreated, Unresectable, Pleural Mesothelioma: The Meso-Immune (Gfpc 04-2021) Trial

Number of pages: 27 Posted: 02 Feb 2024
Olivier Bylicki, Florian Guisier, Arnaud Scherereel, Catherine Daniel, Aurélie Swalduz, Emmanuel Grolleau, Marie Bernadi, Stéphane Hominal, Jean.Briac Prevost, Guillaume Pamart, Marie.Hèlene Marques, Nicolas Cloarec, Simon Deshayes, Judith Raimbourg, Remi Veillon, Youssef Oulkhouir, Clarisse Audigier-Valette, Fabien Subtil, Christos Chouaïd and Laurent Greillier
affiliation not provided to SSRN, Normandie Université, University of Lille, PSL Research University - Institut Curie, University of Claude Bernard Lyon 1 - Centre Léon Bérard, Lyon Sud Hospital - Civils Hospices of Lyon, Institut d'Administration des Entreprises d'Aix-en-Provence (IAE Aix), Centre Hospitalier Pierre Bénite, Clinique Ambroise Paré, University of Strasbourg, Groupe Hospitalier du Havre, Centre Hospitalier Henri Duffaut, University of Caen Normandie - Centre Hospitalier - CHU de Caen, Université de Nantes, University of Bordeaux - CHU de Bordeaux, University of Angers - CHU Angers, CHITS Sainte Musse, Université Lyon 1, Centre Hospitalier Intercommunal de Créteil and Aix-Marseille University
Downloads 71 (875,328)

Abstract:

Loading...

pleural mesothelioma, Immunotherapy, real-world data, survival, safety

2.

A multicenter phase 2 study evaluating Denosumab in combination with Nivolumab as second-line therapy for patients with stage IV non-small–cell lung cancer with bone metastases, DENIVOS-GFPC 06-2017

Number of pages: 21 Posted: 28 Apr 2026
Chantal Decroisette, Isabelle Monnet, Tristan Delory, Charles Ricordel, Axelle Demaegdt, Nicolas Paleiron, Lionel Falchero, Margaux Geier, gregoire Justeau, Marie Bernadi, Virgile Gazaille, Roland Schott, Sabine Vieillot, Pierre-Alexandre Hauss, Sophie Bayle, Melissa Petrier, Florian Guisier, Christos Chouaïd and Laurent Greillier
Institut d’Hématologie et d’Oncologie Pédiatrique (iHOPe) - Centre Léon Bérard, Centre Hospitalier Intercommunal de Créteil, Centre Hospitalier Pierre Bénite - Clinical Research Unit, CHU Rennes, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, CHU de Brest, University of Angers - CHU Angers, Institut d'Administration des Entreprises d'Aix-en-Provence (IAE Aix), affiliation not provided to SSRN, Institut de cancérologie Strasbourg Europe ICANS, Centre Hospitalier de Perpignan, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Normandie Université, Centre Hospitalier Intercommunal de Créteil and Aix-Marseille University
Downloads 25 (1,424,331)

Abstract:

Loading...

non-small cell lung cancer, Bone metastasis, immune checkpoint inhibitor, anti-resorptive agent, skeletal-related events